Work

Immunotherapy and Biomarker Testing in Recurrent and Metastatic Head and Neck Cancers: ASCO Guideline Q and A

Year: 2023

Type: article

Abstract: This Q&A is derived from recommendations in Immunotherapy and Biomarker Testing in Recurrent and Metastatic Head and Neck Cancers: ASCO Guideline.This document is based on an ASCO Guideline and is not intended to substitute for the independent professional judgment of the treating physician.Practice guidelines do not account for individual variation among patients.This Q&A does not purport to suggest any particular course of medical treatment.Use of the guideline and this Q&A are voluntary.Please refer to the complete guideline to understand the full recommendations.

Source: JCO Oncology Practice

DOI: 10.1200/op.22.00802

Authors: Emrullah Yilmaz, Nofisat Ismaila, Raetasha Dabney, Nabil F. Saba, Loren K. Mell

Institutions: Cleveland Clinic, American Society of Clinical Oncology, Center for Cancer and Blood Disorders, Emory University, University of California San Diego

Language: English

Topic: Head and Neck Cancer Studies

Subfield: Otorhinolaryngology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4318154115

FWCI: 0.887

Cites: 14

Cited by: 4

Related to: 10